èšåºæ®µéã®è£œè¬äŒç€Ÿã§ãã Moleculin Biotech, Inc. ã¯ãç±³åœã§æ²»çæµææ§ã®è
«çããã³ãŠã€ã«ã¹ã®æ²»çè¬åè£ã®éçºã«æ³šåããŠããŸããäž»ãªåè£è¬ã¯ãåçºæ§ãŸãã¯é£æ²»æ§ã®æ¥æ§éªšé«æ§çœè¡ç
(AML) ããã³èºã«è»¢ç§»ããçã®æ²»çè¬ãšããŠç¬¬ 1/2 çžè©Šéšãè¡ãããŠãã Annamycin ã§ããå瀟ã®äž»åã®å
ç«/転å調ç¯è¬ã¯ WP1066 ã§ãè³è
«çããã³å°å
è³è
«çãèµèçããã³è¡æ¶²æªæ§è
«çã®æ²»çè¬ãšããŠç¬¬ I çžèšåºè©Šéšãè¡ãããŠããŸãããŸããWP1066 ã®é¡äŒŒäœã§ãã WP1220 ãéçºããŠãããããŒã©ã³ãã§ç®è T 现èãªã³ãè
«ã®å±ææ²»çè¬ãšããŠç¬¬ 1 çžèšåºè©Šéšãå®äºããŠããŸãã WP1066ã®é¡äŒŒäœã§ããWP1732ã¯ãç®èT现èãªã³ãè
«ã®å±ææ²»çè¬ã§ããå瀟ã®äž»å代è¬/ç³åé»å®³ååç©ã¯ãããããŠã€ã«ã¹ã®æ²»çè¬ã§ããWP1122ã§ããããã«ãè§£ç³ãšç³åãæšçãšããä»ã®å
ç«/転å調ç¯å€ãä»£è¬æ®æå€ãªã©ãä»ã®è¬å€åè£ã®åèšåºéçºã«ãåãçµãã§ããŸããå瀟ã¯ãããŸããŸãªè¬å€åè£ã®éçºã®ããã«ãMDã¢ã³ããŒãœã³ãDERMIN Sp. z ooãAnimal Life SciencesãLLCãWPD Pharmaceuticals Sp zooãšææºããã³ååå¥çŽãçµãã§ããŸããMoleculin Biotech, Inc.ã¯2015幎ã«èšç«ããããããµã¹å·ãã¥ãŒã¹ãã³ã«æ¬ç€Ÿã眮ããŠããŸãã